Blood transfusion is a salutary practice in modern medicine, but it carries a high risk of transmission of transfusion transmitted infections (TTIs), especially in developing countries. The objective of this study is to determine the seroprevalence of viral hepatitis B among blood donors. This is a retrospective and descriptive cross-sectional study of the period from 2014 to 2016 at the Katele Health Reference Center (Moba, DR. Congo). We investigated HBsAg in blood donors by using Determine ® HBSAg. 1145 blood donors with an age mean of 30.6 ± 6.9 years and predominantly male (62.5%) were retained. 
Introduction
Blood transfusion is a salutary practice of modern medicine for the management of severe anemias that urgently need blood [1] . Blood transfusion has been used for more than eighty years and presents risks of transmission of infectious agents transmitted by transfusion [1] - [8] . These agents include the human immunodeficiency virus (HIV), hepatitis B virus (HBV), hepatitis C virus (HCV), hepatitis E virus, Treponema pallidum, Trypanosoma cruzi and brucei (T. brucei brucei and T. brucei gambiense), Cytomegalovirus, Human T lymphocyte virus, etc. [4] [5] [6] [8] [9] [10] [11] . In this study, research is being conducted on the hepatitis B virus (hepatotropic Hepadnaviridae family) in blood donors. [2] [12]. It is a serious public health problem [2] [12] [13] [14] and patients are at risk of liver cirrhosis and hepatocarcinoma [2] [7] [10] [12] [13] which can lead to hepatic encephalopathy, due to insufficiency Hepatocellular, and death [2] [9]
Viral hepatitis B (HVB) is an inflammation of the liver with impairment of hepatocytes that degenerate following infection with hepatitis B virus (HBV)
[10] [13] . Around 240 million people are infected with chronic viral hepatitis and more than six hundred and eighty-six thousand individuals die each year as a result of HVB and its consequences [2] . East Asia and sub-Saharan Africa regions are the most affected [2] [15] . HBV is endemic with a different prevalence in different regions of the world [13] . The seroprevalence of markers of hepatitis B virus infection is an indicator that has been variously appreciated among blood donors worldwide: 20% in Tanzania [16] ; in Nigeria 14.0% in 2000-2013 [17] and 11.1% in Kano [18] ; 10.01% in Equatorial Guinea [10] ; 10.0% in Cameroon [19] ; 4.7% in Ethiopia [20] ; 2.8% in Rwanda [21] ; 1.2% in Nepal [22] ; 1.1% in India [1] and 0.6% in Namibia [23] , etc.
In the Democratic Republic of Congo, the seroprevalence of hepatitis B virus infection among blood donors is 1.6% to 9.2%: Kinshasa 9.2% [24] , Lubumbashi 8.0% [25] and 6.8% [6] , Kisangani 6.0% [26] , Bukavu 3.7% [27] and 1.6% in rural areas of Kamina [28] . In Moba, there are no studies evaluating the seroprevalence of hepatitis B (carriage of HBS antigen) among blood donors. The objective of this study is to determine the seroprevalence of hepatitis B (HBsAg) among blood donors at the Katele Health Center in Moba. It will allow future researchers (local and non-local) and the national blood transfusion program (NBTP) to have a reference in the epidemiological follow-up of HBV infections.
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Materials and Methods
Site, Type and Study Periods
This is a cross-sectional retrospective and descriptive study carried out at the Katele Reference Center in Moba from 2014 to 2016, i.e. three years. The Katele Reference Health Center (RHC) is located in Moba-Port, in the health area of Moba-Port (population 2017: 25,266 inhabitants), mainly on the shores of Tanganyika Lake, in the health zone of Moba, Province of Tanganyika in the DRC. It covers an estimated population of more than 60 thousand inhabitants, mainly from health areas along Tanganyika Lake (Regezza, Mulunguzi, Kansenge, Liombe, etc.) over a distance of more than 70 km. The main diseases encountered are, in order of importance: malaria, acute respiratory infections, simple diarrhea, dysentery (especially in artisanal mineral extraction areas), measles, cholera (seasonal pattern) and sexually transmitted infections (STI).
The territory of Moba has an area of 24,500 km 2 and 609,406 inhabitants, i.e. a density of 24.9 inhabitants/km 2 [29] . The ethnic populations are predominantly Tabwa (over 80%), Bemba and Luba. There are also other tribes from the DRC and neighboring countries (Tanzania and Zambia). The main activities include agriculture and fisheries. This fishery on Tanganyika Lake attracts people from several towns in the DRC and neighboring countries: Kalemie, Mbuji-Mayi, Kananga, Uvira, Bukavu, Lubumbashi, Kolwezi, Pweto and Kirando (Tanzania). This fishery concerns the species specific to Tanganyika Lake, namely Stolothrissa tanganikae (locally called "DAGA") and Luciolates (locally called "MUKEBUKA").
Population and Parameters Studied
Our study population consisted of all blood donors of the period concerned (n = 1145). The age, sex, type of blood donation (family, irregular volunteer circumstantial or paid) and the result of the serological investigation of the HBS Antigen were the desired parameters. 
Method of Determination of Viral Hepatitis B
Data Processing and Analysis
The data collected on a pre-established form were encoded on the Excel table The association between the variables studied was assessed using the unadjusted Pearson chi-square test. The allowed alpha error was 5% and any value of p ≤ 0.05 was considered significant.
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Results
The results of this study concern the 1145 blood donors registered during the study period at the Katele Health Reference Center (Moba, DRC) laboratory. Of the 1145 blood donors examined, 926 (80.9%) were between 18 and 38 years of age. The mean age was 30.6 ± 6.9 years with extremes ranging from 18 to 49 years (Table 1) . Men were the most represented among blood donors followed by women with respectively 715 (62.5%) and 430 (37.5%). In terms of blood donor categories (types), family donors were the most commonly encountered: 953 (83.2%), followed by paid donors (n = 112 or 9.8%) and irregular volunteers (n = 80 or 7.0%). The proportion of voluntary blood donations was lowest and only concerns circumstantial irregular voluntary donors ( Table 1 ).
The study of the prevalence of viral hepatitis B (HBsAg) in our study series revealed a seroprevalence of 3.9% (n = 45) over three years ( Figure 2 ). The year 2015 was the most contributory with 9.4% (n = 42 out of 448 registered blood donors).
The years 2014 and 2016 had very low seroprevalence with respectively 0.3% (n = 1 of 393 donors) and 0.7% (n = 2 of 304 blood donors). Throughout the study period, cases of HBV infection were only registered in the family donor category, i.e. 100%. HBsAg seropositivity cases (HBsAg carriers) had an average age of 29.6 ± 7.2 years and extremes of 19 -42 years. The seronegatives had an average age of 31.1 ± 6.8 years and the extremes of 18 to 49 years (Table 1) .
Among the carriers of HBsAg, the female (n = 19 or 4.4%) and the 18 to 38 years age group were most significantly affected (p > 0.05). 
Discussion
Characteristics of Blood Donors
During the period of our study on the prevalence of HBV infection in blood do- [26] , blood donors were mainly women. The arguments favoring male predominance take into account the cultural habits and certain physiological predispositions of women to be excluded from the category of blood donors. Indeed, on the one hand to give blood, the donor must feel stronger and fit for that responsibility. In Africa, it is the man who is considered to be the strongest and responsible for any situation that threatens the family: therefore it is better able to give blood than the woman. On the other hand, pregnancy and breastfeeding are contraindications to blood donation, which would reduce women's chances of donating blood. Some authors also mention menstrual blood loss in women [5] 
The Seroprevalence of HBV Infection in Blood Donors
In Africa, the prevalence of HBV infection is 0.2% to 20% among blood donors [5] [10]. The cumulative seroprevalence of HBV infection (HBsAg) during the three years of study was 3.9%. It is close to the results encountered by Kabinda [33] 4.2% and Namululi [27] [20] and 8.8 in Uganda [21] . However, it is higher than India's 1.1% [1] , in Nepal 1.2% [22] , in Canada 0.007% to 0.06% [46] , in Iran 0.15% [47] , China 1.085% [48] , Italy 0.007 [49] and Rwanda 2.8% [21] .
In the Democratic Republic of Congo, this seroprevalence is lower than Kakisingi [25] 8.01% and Michel [6] 6.8% in Lubumbashi, Batina in Kisangani 6.0% [7] , Mbendi in Kinshasa 9.2% [24] ; greater than 1.6% obtained by Kabamba Nzaji [28] in rural Kamina; and close to 3.7% of Namululi [27] and Kabinda [33] 4.2% of volunteer donors in Bukavu. Infectious risk in blood recipients appears to be certain in all provinces of the DRC and viral hepatitis B continues to be the reason for exclusion from donating blood. This risk is more acute in developing B. H. Kabemba et al.
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The time-series trend in the evolution of the seroprevalence of HBV infection in our study does not make it possible to give a serious and accurate judgment on the evolution of HBV infection in our environment. The peak was observed in 2015 with 9.4% while 0.3% in 2014 and 0.7% in 2106. It would be necessary to wait for the evolution of this seroprevalence in the following years to make the judgment. However, we believe that on the whole, this fluctuating behavior would be influenced by family donors known as donors at risk of transfusion-transmitted infection (TTIs) [32] [40] [41] [51].
In our study, the observed seroprevalence of HBV infection in females (4.4%) was higher than that of males (3.6%). The difference observed is not statistically significant (p > 0.05). This was mentioned by Michel [6] in the DRC. Similarly, the prevalence of HBSAg in blood donors aged 18 to 38 (4.2%) and 39 to 58 years (2.7%) was not statistically significant (p > 0.05). Unlike Xie [10], for who age was associated with the high seroprevalence of HBV infection in Equatorial Guinea. On the other hand, the blood donation category is associated with HBV infection.
Family donors were the only ones affected by HBV in our series and the difference observed was significant (p < 0.05) [6] . It is here that the need for NBTP to organize public awareness campaigns in favor of regular voluntary blood donations in order to achieve the WHO 2020 targets: 100% voluntary donations [52] .
For this study, age and sex are not statistically associated with the occurrence of Hepatitis B infection. Michel [6] and Batina [7] fund the significative association between age and the AgHBSAg in Lubumbashi and Kisangani (DRC). The rural environment has been identified as associated with the risk of transmission of hepatitis B by Kabinda [33] , which requires the strengthening of epidemiological surveillance measures for blood donors.
From the Method of Screening and Diagnosis of HBV Infection: Qualitative Assay of HBsAg
Apart from the risk of contamination of the blood recipient during the transfusion discussed in this work, it is useful to highlight the limits of our strategy of securing blood donations. Indeed, in addition to the fact that the NBTP recommends the use of a single rapid diagnostic test (RDT) to assess the risk of HBV infection, Determine HBsAg tests are recognized to be less sensitive in some studies [53] [54] [55] . The ELISA chain can be considered as an alternative for confirmation of the results [25] [26] [34] . In Madagascar, in the CHUA-JRA Ampefiloha Immunology laboratory, the results obtained during the evaluation of the rapid tests for the detection of HBsAg showed a sensitivity of 96.1%, a specificity B. H. Kabemba et al.
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A study conducted in India [56] Blanco et al. [61] in Argentina, the nucleic acid test contributes greatly in reducing the potential infectious risks of transmission of hepatitis B virus.
Anti-HBc is the first antibody to appear in serum following exposure to HBV, less than one month after the onset of HBsAg. It is not recommended for the detection of hepatitis B but is a useful marker in the context of acute hepatitis B diagnosis in endemic areas [24] [59]. In Malaysia, one thousand HBsAg negative subjects were found to be 87.3% positive for Anti-HBc by ELISA [43] . However in our context, no paraclinic examination is very necessary than the better selection of blood donor candidates (pre-test counseling).
Securing blood donations is a responsibility of the government [50] and its partners who should make better supplies of good quality blood to the Congolese population. This includes regular voluntary donations, good quality pre-test counseling, more effective screening and diagnostic tests, training of blood transfusion personnel and the availability of sufficient blood banks and epidemiological follow-up Seroprevalence in both urban and rural areas.
Conclusion
The results of our study demonstrate the need for epidemiological monitoring of blood donations and the strengthening of transfusion safety measures. The overall seroprevalence of HBsAg of 3.9% over three years was influenced by the highest peak observed in 2015 (9.4%), while prevalences of 0.3% and 0.7% were observed 
